Expert review of the evidence base for prevention of travelers' diarrhea (Q34987670)

5 August 2017

1 reference

title

Expert review of the evidence base for prevention of travelers' diarrhea (English)

1 reference

5 August 2017

0 references

1

Herbert L DuPont

1 reference

5 August 2017

3

Michael J G Farthing

1 reference

5 August 2017

Charles D Ericsson

2

1 reference

5 August 2017

Sherwood Gorbach

4

1 reference

5 August 2017

Larry K Pickering

5

1 reference

5 August 2017

Lars Rombo

6

1 reference

5 August 2017

Robert Steffen

7

1 reference

5 August 2017

Thomas Weinke

8

1 reference

5 August 2017

19 March 2009

1 reference

Journal of Travel Medicine

5 August 2017

1 reference

5 August 2017

16

1 reference

5 August 2017

3

1 reference

5 August 2017

149-160

1 reference

Travelers' Diarrhea and ToxigenicEscherichia coli

5 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Diarrheal illness among deployed U.S. military personnel during Operation Bright Star 2001--Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Risk of Cholera Among Western and Japanese Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

The true burden and risk of cholera: implications for prevention and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with travelers' diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Epidemiology of diarrhea among expatriate residents living in a highly endemic environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Persistent high risk of diarrhea among foreigners in Nepal during the first 2 years of residence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Etiology of Diarrhea Among Travelers and Foreign Residents in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Location of food consumption and travelers' diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Human rotavirus in an adult population with travelers' diarrhea and its relationship to the location of food consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Bacterial Enteric Pathogens in Uncooked Foods in Thai Markets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Looking for evidence that personal hygiene precautions prevent traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Epidemiology of diarrhea in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Structural mechanism for rifampicin inhibition of bacterial rna polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

The practice of travel medicine: guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Lactulose Therapy in Shigella Carrier State and Acute Dysentery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Meta-analysis of probiotics for the prevention of traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Field trial of oral cholera vaccines in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea, by use of the polymerase chain reaction technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Evaluation of colony-based examinations of diarrheagenic Escherichia coli in stool specimens: low probability of detection because of low concentrations, particularly during the early stage of gastroenteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

How to hit the runs for fifty million travelers at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Cholera, non-vibrio cholera, and stomach acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Prophylactic immunization against enterotoxin-forming Escherichia coli travellers' diarrhea and cholera: does it make sense and for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2008.00299.X

10.1111/J.1708-8305.2008.00299.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference